Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
DNLI on Nasdaq
There are no Buy or Sell transactions made by Marc Tessier-Lavigne since 08 Feb 2025
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,886,576 |
$31,015,309 |
$16.44 |
03 Jun 2025 |
Direct |
|
|
| Common Stock |
79,173 |
$1,301,604 |
$16.44 |
03 Jun 2025 |
The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
|
|
| Common Stock |
78,848 |
$1,296,261 |
$16.44 |
03 Jun 2025 |
The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
|
|
| Common Stock |
78,848 |
$1,296,261 |
$16.44 |
03 Jun 2025 |
The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
|
|
| Stock Option (right to buy) |
18,111 |
|
|
03 Jun 2025 |
Direct |
Common Stock |
|
Transactions reported by Marc Tessier-Lavigne for Denali Therapeutics Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.